Evaluation and Importance of the PD-1/PD-L1 and the IL-10/IL-10R Axis in Malignant and Benign Pleural Effusions - a Pilot Study

NCT04834830 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-04-08

No results posted yet for this study

Summary

The aim of this study is to evaluate the concentrations of interleukin-2, interleukin-10, interferon-gamma, PD1+ lymphocytes, and the interleukin-10 receptor expression in malignant and benign effusions.

Conditions

  • Pleural Effusion

Interventions

DIAGNOSTIC_TEST

Pleural effusion will be examined for various cytokines and PD1-lymphocytes.

Examination of pleural effusion

Sponsors & Collaborators

  • University of Vienna

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-04-01
Completion
2022-04-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04834830 on ClinicalTrials.gov